vs
Esperion Therapeutics, Inc.（ESPR）与MONRO, INC.（MNRO）财务数据对比。点击上方公司名可切换其他公司
MONRO, INC.的季度营收约是Esperion Therapeutics, Inc.的1.7倍（$293.4M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -4.0%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -2.7%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
蒙罗公司（Monro, Inc.）是一家汽车服务企业，创始并总部设在美国纽约州罗切斯特。截至2025年，蒙罗共拥有1260家门店，按门店数量与营收计算，是北美仅次于Driven Brands的第二大汽车服务企业。
ESPR vs MNRO — 直观对比
营收规模更大
MNRO
是对方的1.7倍
$168.4M
营收增速更快
ESPR
高出147.8%
-4.0%
两年增速更快
ESPR
近两年复合增速
-2.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $293.4M |
| 净利润 | — | $11.1M |
| 毛利率 | — | 34.9% |
| 营业利润率 | 50.6% | 6.3% |
| 净利率 | — | 3.8% |
| 营收同比 | 143.7% | -4.0% |
| 净利润同比 | — | 143.1% |
| 每股收益（稀释后） | $0.32 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRMNRO
| Q4 25 | $168.4M | $293.4M | ||
| Q3 25 | $87.3M | $288.9M | ||
| Q2 25 | $82.4M | $301.0M | ||
| Q1 25 | $65.0M | $295.0M | ||
| Q4 24 | $69.1M | $305.8M | ||
| Q3 24 | $51.6M | $301.4M | ||
| Q2 24 | $73.8M | $293.2M | ||
| Q1 24 | $137.7M | $310.1M |
净利润ESPRMNRO
| Q4 25 | — | $11.1M | ||
| Q3 25 | $-31.3M | $5.7M | ||
| Q2 25 | $-12.7M | $-8.1M | ||
| Q1 25 | $-40.5M | $-21.3M | ||
| Q4 24 | — | $4.6M | ||
| Q3 24 | $-29.5M | $5.6M | ||
| Q2 24 | $-61.9M | $5.9M | ||
| Q1 24 | $61.0M | $3.7M |
毛利率ESPRMNRO
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 35.5% |
营业利润率ESPRMNRO
| Q4 25 | 50.6% | 6.3% | ||
| Q3 25 | -11.4% | 4.4% | ||
| Q2 25 | 8.6% | -2.0% | ||
| Q1 25 | -34.0% | -8.1% | ||
| Q4 24 | -6.4% | 3.3% | ||
| Q3 24 | -31.0% | 4.4% | ||
| Q2 24 | 3.5% | 4.5% | ||
| Q1 24 | 52.5% | 3.3% |
净利率ESPRMNRO
| Q4 25 | — | 3.8% | ||
| Q3 25 | -35.9% | 2.0% | ||
| Q2 25 | -15.4% | -2.7% | ||
| Q1 25 | -62.2% | -7.2% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | -57.2% | 1.9% | ||
| Q2 24 | -83.9% | 2.0% | ||
| Q1 24 | 44.3% | 1.2% |
每股收益（稀释后）ESPRMNRO
| Q4 25 | $0.32 | $0.35 | ||
| Q3 25 | $-0.16 | $0.18 | ||
| Q2 25 | $-0.06 | $-0.28 | ||
| Q1 25 | $-0.21 | $-0.74 | ||
| Q4 24 | $-0.14 | $0.15 | ||
| Q3 24 | $-0.15 | $0.18 | ||
| Q2 24 | $-0.33 | $0.19 | ||
| Q1 24 | $0.34 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $4.9M |
| 总债务越低越好 | — | $45.0M |
| 股东权益账面价值 | $-302.0M | $604.9M |
| 总资产 | $465.9M | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ESPRMNRO
| Q4 25 | $167.9M | $4.9M | ||
| Q3 25 | $92.4M | $10.5M | ||
| Q2 25 | $86.1M | $7.8M | ||
| Q1 25 | $114.6M | $20.8M | ||
| Q4 24 | $144.8M | $10.2M | ||
| Q3 24 | $144.7M | $20.9M | ||
| Q2 24 | $189.3M | $18.7M | ||
| Q1 24 | $226.6M | $6.6M |
总债务ESPRMNRO
| Q4 25 | — | $45.0M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $71.5M | ||
| Q1 25 | — | $61.3M | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | — | $62.0M | ||
| Q2 24 | — | $112.0M | ||
| Q1 24 | — | $102.0M |
股东权益ESPRMNRO
| Q4 25 | $-302.0M | $604.9M | ||
| Q3 25 | $-451.4M | $601.7M | ||
| Q2 25 | $-433.5M | $604.9M | ||
| Q1 25 | $-426.2M | $620.8M | ||
| Q4 24 | $-388.7M | $648.9M | ||
| Q3 24 | $-370.2M | $651.9M | ||
| Q2 24 | $-344.2M | $654.4M | ||
| Q1 24 | $-294.3M | $656.8M |
总资产ESPRMNRO
| Q4 25 | $465.9M | $1.6B | ||
| Q3 25 | $364.0M | $1.6B | ||
| Q2 25 | $347.1M | $1.6B | ||
| Q1 25 | $324.0M | $1.6B | ||
| Q4 24 | $343.8M | $1.7B | ||
| Q3 24 | $314.1M | $1.7B | ||
| Q2 24 | $352.3M | $1.7B | ||
| Q1 24 | $373.1M | $1.7B |
负债/权益比ESPRMNRO
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $17.8M |
| 自由现金流经营现金流 - 资本支出 | — | $9.1M |
| 自由现金流率自由现金流/营收 | — | 3.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.0% |
| 现金转化率经营现金流/净利润 | — | 1.60× |
| 过去12个月自由现金流最近4个季度 | — | $49.6M |
8季度趋势，按日历期对齐
经营现金流ESPRMNRO
| Q4 25 | $45.2M | $17.8M | ||
| Q3 25 | $-4.3M | $32.3M | ||
| Q2 25 | $-31.4M | $-1.9M | ||
| Q1 25 | $-22.6M | $28.9M | ||
| Q4 24 | $-35.0M | $14.8M | ||
| Q3 24 | $-35.3M | $62.6M | ||
| Q2 24 | $-7.2M | $25.6M | ||
| Q1 24 | $53.8M | $-5.3M |
自由现金流ESPRMNRO
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $26.6M | ||
| Q2 25 | — | $-9.3M | ||
| Q1 25 | — | $23.2M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | $-35.5M | $57.6M | ||
| Q2 24 | $-7.3M | $16.8M | ||
| Q1 24 | $53.8M | $-11.9M |
自由现金流率ESPRMNRO
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 9.2% | ||
| Q2 25 | — | -3.1% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -68.7% | 19.1% | ||
| Q2 24 | -9.9% | 5.7% | ||
| Q1 24 | 39.0% | -3.8% |
资本支出强度ESPRMNRO
| Q4 25 | 0.0% | 3.0% | ||
| Q3 25 | 0.0% | 2.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 2.2% | ||
| Q3 24 | 0.3% | 1.6% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.1% | 2.1% |
现金转化率ESPRMNRO
| Q4 25 | — | 1.60× | ||
| Q3 25 | — | 5.71× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.23× | ||
| Q3 24 | — | 11.08× | ||
| Q2 24 | — | 4.37× | ||
| Q1 24 | 0.88× | -1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
